By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Asterias Biotherapeutics 

230 Constitution Drive

Menlo Park  California  94025  U.S.A.
Phone: 650-433-2992 Fax: n/a


SEARCH JOBS


Industry
Biotechnology






Company News
Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer 9/11/2014 7:26:28 AM
Asterias Biotherapeutics Announces Record Date For Distribution Of BioTime (BTX) Warrants To Holders Of Asterias Series A Common Stock 9/8/2014 9:17:49 AM
BioTime (BTX) Subsidiary Asterias Biotherapeutics Receives FDA Clearance To Initiate Phase 1/2a Clinical Trial Of AST-OPC1 In Patients With Cervical Complete Spinal Cord Injury 8/27/2014 10:56:06 AM
Asterias Biotherapeutics Receives U.S. FDA Clearance To Initiate Phase 1/2a Clinical Trial Of AST-OPC1 In Patients With Cervical Complete Spinal Cord Injury 8/27/2014 7:50:13 AM
Asterias Biotherapeutics Announces Investor Briefing Conference Call And Webcast 8/25/2014 9:05:08 AM
Asterias Biotherapeutics Appoints Two Independent Directors And Announces Completion Of Series A Common Stock Distribution 8/21/2014 8:02:08 AM
Asterias Biotherapeutics Announces Live Investor Webcast 7/25/2014 8:08:28 AM
BioTime (BTX) Subsidiary Asterias Biotherapeutics Announces Investment By CEO 6/17/2014 10:16:15 AM
BioTime (BTX) Subsidiary Asterias Biotherapeutics Raises $13.0 Million In Equity Financing 6/17/2014 10:14:07 AM
Asterias Biotherapeutics Brings In Ex-Pfizer Inc. (PFE) Senior Executive Pedro Lichtinger As President And CEO 6/12/2014 8:11:35 AM
12
//-->